Financial statements Gardenpharm W Likwidacji
Balance sheet data of GARDENPHARM W LIKWIDACJI
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|---|
Total assets | 31 670 580,28 | 26 197 078,99 | 15 692 400,69 | 7 830 465,20 | 4 333 300,50 | 4 014 158,70 |
A. Fixed assets | 5 634 757,12 | 997 628,88 | 1 039 645,29 | 1 704 238,45 | 1 177 219,31 | 1 121 747,91 |
B. Current assets | 26 035 823,16 | 25 199 450,11 | 14 652 755,40 | 6 126 226,75 | 3 156 081,19 | 2 892 410,79 |
C. Share capital contributions (basic funds) | - | - | - | - | - | - |
D. Own shares (stocks) | - | - | - | - | - | - |
Total liabilities | 31 670 580,28 | 26 197 078,99 | 15 692 400,69 | 7 830 465,20 | 4 333 300,50 | 4 014 158,70 |
A. Equity | -8 714 519,46 | -12 368 124,18 | -15 856 901,08 | -16 347 592,34 | -14 582 762,28 | -14 174 034,57 |
B. Liabilities and provisions for liabilities | 40 385 099,74 | 38 565 203,17 | 31 549 301,77 | 24 178 057,54 | 18 916 062,78 | 18 188 193,27 |
I. Long-term liabilities | 31 961 871,20 | 30 335 177,27 | 23 870 209,57 | 16 634 735,21 | 15 941 809,81 | 15 401 809,81 |
II. Short-term liabilities | 8 309 826,15 | 8 152 534,55 | 7 600 596,76 | 7 533 322,33 | 2 968 352,97 | 2 759 742,46 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.